Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone
Year: 2011
Type: article
Source: Arthritis & Rheumatism
DOI: 10.1002/art.30385
Institution: UCB Pharma (United Kingdom)
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Amgen, UCB Celltech
OpenAlex ID: W2057472181
